NVNO
enVVeno Medical Corp
Key Financials
Revenue
$31243
0.0%
Operating Income
$-20899000
↑ 12.3%
Gross Profit
$186552
↑ 7508.2%
Net Income
$-19472000
↑ 10.8%
EPS (Diluted)
$-33.06
↓ 2503.1%
Total Assets
$29.6M
↓ 34.2%
Total Liabilities
$2.4M
↓ 13.0%
Cash & Equivalents
$3.1M
↑ 74.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 7/30/2026 | View on SEC |
| 8-K | 7/14/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 144 | 6/11/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| 8-K | 4/29/2026 | View on SEC |
| S-8 | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NVNO |
| Company Name | enVVeno Medical Corp |
| CIK | 1661053 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-261-2900 |